P2X7 purinergic
Selected indexed studies
- Radioligands targeting purinergic P2X7 receptor. (Bioorg Med Chem Lett, 2020) [PMID:32273217]
- Purinergic P2X7 receptor as a potential therapeutic target in depression. (Biochem Pharmacol, 2024) [PMID:38052270]
- Ionotropic purinergic receptor 7 (P2X7) channel structure and pharmacology provides insight regarding non-nucleotide agonism. (Channels (Austin), 2024) [PMID:38762911]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Radioligands targeting purinergic P2X7 receptor. (2020) pubmed
- Purinergic P2X7 receptor as a potential therapeutic target in depression. (2024) pubmed
- Ionotropic purinergic receptor 7 (P2X7) channel structure and pharmacology provides insight regarding non-nucleotide agonism. (2024) pubmed
- Purinergic P2X7 Receptor: A Cation Channel Sensitive to Tumor Microenvironment. (2019) pubmed
- The P2X7 purinergic receptor: a potential therapeutic target for lung cancer. (2020) pubmed
- The P2X7 purinergic receptor: An emerging therapeutic target in cardiovascular diseases. (2018) pubmed
- Purinergic P2X7 receptors as therapeutic targets in interstitial cystitis/bladder pain syndrome; key role of ATP signaling in inflammation. (2019) pubmed
- Purinergic receptor P2X₇: a novel target for anti-inflammatory therapy. (2014) pubmed
- The P2X7 Receptor in Infection and Inflammation. (2017) pubmed
- Structure-Activity Relationships and Therapeutic Potential of Purinergic P2X7 Receptor Antagonists. (2024) pubmed